Scottsdale, Arizona 9/12/2009 2:33:18 AM
News / Business

BIO-key International, Inc.’s (BKYI.OB) Biometric Technology Selected for Next Generation FBI AFIS System

QualityStocks would like to highlight BIO-key International, Inc. (OTCBB: BKYI). The company develops and delivers advanced identification solutions and information services to law enforcement departments, public safety agencies, government and private sector customers. BIO-key's mobile wireless technology provides first responders with critical, reliable, real-time data and images from local, state and national databases.

 

In the company’s news yesterday,

 

BIO-key International, Inc. announced that it has been awarded a contract by Lockheed Martin to provide fingerprint identification technology for the FBI’s Next Generation Identification (NGI) system. “This is the most important award the company has ever received and it may be the most important biometric contract ever awarded”, stated Mike Depasquale, BIO-key’s CEO.

 

The U.S. FBI is regarded as the most discerning and most demanding fingerprint user in the world. According to the press release, the award of the contract was the result of a competitive trade study process that rigorously and objectively evaluated vendors’ solutions. BIO-key and MorphoTrak were able to fuse their two fingerprint biometric algorithms to deliver unparalleled speed and accuracy from a single fingerprint sample.

 

“We appreciate the privilege of being selected to be part of this vital national identification project along with MorphoTrak and we look forward to working with the FBI and its contractors including Lockheed Martin to successfully implement and support the most advanced biometric system ever deployed,” commented DePasquale.

 

“The results we have been able to achieve are extraordinary,” added Mira LaCous, Vice President of Technology and Development. “BIO-key’s core algorithm accuracy and image enhancement/ correction solutions provided major improvements to the FBI’s current system and we believe surpassed all other competing technologies. This technology, developed here in the United States, that BIO-key provided to MorphoTrak is being used today by BIO-key customers in commercial applications as well as other major large scale civil ID programs,” continued Ms. LaCous.

 

“We believe the selection of BIO-key technology by the FBI, through their contractors Lockheed Martin and MorphoTrak, to be part of the NGI system, validates that BIO-key has some of the industry’s most accurate and scalable fingerprint matching technology. Other agencies and commercial customers, looking to take advantage of the research, testing and decision by the FBI may now reasonably conclude: “If it is good enough for the FBI, it’s certainly good enough for our organization”. We are thrilled with how well BIO-key is positioned and with the quality of our references as we look to our future biometric business potential”, DePasquale concluded.

 

About QualityStocks

 

QualityStocks, based in Scottsdale, Arizona is a free service that collects data from hundreds Small-Cap and Micro-Cap online Investment Newsletters into one Free Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their advertising efforts and now has over 750,000+ subscribers that receive The Daily Stock Newsletters.

 

Please see disclaimer on QualityStocks website: http://Disclaimer.QualityStocks.net 

 

Forward-Looking Statement:

This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.